StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
10
Publishing Date
2021 - 11 - 15
10
Sector
Health technology
10
Tags
Acquisition
6
Audio
4
Biopharma
4
Bioscience
6
Biotech-bay
4
Biotech-beach
4
Biotechnology
4
Brands
5
Cancer
5
Ceo
6
Clinical-trials-phase-ii
9
Collaboration
4
Conference
31
Contract
5
Covid
10
Deadline
4
Designation
6
Diagnostic
4
Diagnostics
4
Disease
6
Drug
9
Earnings
13
Ema
13
Energy
14
Enroll
4
Events
8
Financial results
73
Granted
8
Growth
8
Heart
8
Iot
7
Liver
6
Market
4
Media
5
Merge
8
N/a
456
Offering
15
Order
4
Partnership
5
People
6
Phase 1
5
Phase 2
10
Phase 2b
4
Phase 3
8
Platform
6
Positive
9
Potential
5
Preclinical
4
Presentation
10
Publication
4
Research
19
Results
107
Sales
5
Security
4
Technology
12
Test
4
Therapeutics
7
Therapy
5
Travel
5
Trial
17
Entities
Addex therapeutics ltd
1
Anaptysbio, inc.
1
Arrowhead pharmaceuticals, inc.
1
Bristol-myers squibb company
1
Johnson & johnson
2
Metacrine, inc.
1
Moderna, inc.
1
Novocure limited
1
Protagonist therapeutics, inc.
1
Redhill biopharma ltd.
1
Rocket pharmaceuticals, inc.
1
Symbols
ADXN
1
ANAB
1
ARWR
1
BMY
1
JNJ
2
MRNA
1
MTCR
1
NVCR
1
PTGX
1
RCKT
1
RDHL
1
Exchanges
Nasdaq
9
Nyse
3
Crawled Date
2022 - 09 - 12
9
2022 - 05 - 27
7
2022 - 03 - 15
10
2022 - 01 - 18
8
2022 - 01 - 05
8
2021 - 12 - 16
10
2021 - 12 - 14
10
2021 - 12 - 13
10
2021 - 12 - 10
7
2021 - 12 - 06
17
2021 - 12 - 01
9
2021 - 11 - 29
9
2021 - 11 - 15
10
2021 - 10 - 27
8
2021 - 10 - 13
7
2021 - 10 - 04
10
2021 - 09 - 29
8
2021 - 09 - 28
10
2021 - 09 - 27
7
2021 - 09 - 22
7
2021 - 09 - 20
7
2021 - 09 - 15
7
2021 - 09 - 13
13
2021 - 09 - 09
9
2021 - 09 - 08
7
2021 - 09 - 01
7
2021 - 07 - 19
7
2021 - 07 - 06
7
2021 - 06 - 30
11
2021 - 06 - 29
8
2021 - 06 - 28
11
2021 - 06 - 24
8
2021 - 06 - 23
10
2021 - 06 - 22
7
2021 - 06 - 21
7
2021 - 06 - 16
10
2021 - 06 - 11
10
2021 - 06 - 10
7
2021 - 06 - 09
10
2021 - 06 - 08
10
2021 - 06 - 07
11
2021 - 06 - 04
7
2021 - 05 - 20
7
2021 - 05 - 12
7
2021 - 04 - 20
7
2021 - 04 - 12
7
2021 - 04 - 06
8
2021 - 03 - 22
7
2021 - 03 - 16
8
2021 - 03 - 15
8
2021 - 02 - 25
9
2021 - 02 - 04
8
2021 - 01 - 25
7
2020 - 12 - 21
6
2020 - 12 - 17
12
2020 - 12 - 15
9
2020 - 12 - 09
8
2020 - 12 - 07
8
2020 - 12 - 03
7
2020 - 12 - 01
10
Crawled Time
09:00
1
12:00
1
13:00
2
14:00
2
15:00
1
17:00
1
18:00
1
19:00
1
Source
ir.anaptysbio.com
1
www.biospace.com
7
www.metacrine.com
1
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Phase 2
crawled date :
2021 - 11 - 15
save search
Arrowhead Collaborator Presents Phase 2b Clinical Data from REEF-1 Study in Patients with Chronic Hepatitis B Infection
Published:
2021-11-15
(Crawled : 19:00)
- biospace.com/
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-13.64%
|
O:
-1.36%
H:
0.0%
C:
0.0%
ARWR
|
$22.52
-4.86%
-5.11%
1.1M
|
Health Technology
|
-68.81%
|
O:
-3.29%
H:
0.86%
C:
-10.19%
phase 2
hepatitis
phase 2b
injection
infections
chronic hepatitis b
Metacrine Reports Topline Results for MET409 Phase 2a Combination Trial In Patients with Type 2 Diabetes and NASH
Published:
2021-11-15
(Crawled : 18:00)
- metacrine.com
MTCR
|
$0.5814
-5.14%
84K
|
Health Technology
|
-53.49%
|
O:
1.6%
H:
2.36%
C:
-0.79%
diabetes
phase 2
results
topline
nash
trial
phase 2b
Late-Breaking Phase 2 Data for Investigational Oral Factor XIa Inhibitor Milvexian Suggest Favorable Antithrombotic Profile Across a Wide Range of Doses
Published:
2021-11-15
(Crawled : 17:00)
- biospace.com/
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-17.98%
|
O:
1.63%
H:
0.43%
C:
-0.3%
phase 2
RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients
Published:
2021-11-15
(Crawled : 15:00)
- biospace.com/
RDHL
|
$0.3935
2.21%
2.16%
240K
|
Health Technology
|
-92.21%
|
O:
-2.83%
H:
0.0%
C:
0.0%
covid
phase 2
biopharma
ongoing
phase 2/3
AnaptysBio Announces Positive Rosnilimab Healthy Volunteer Phase 1 Top-Line Data
Published:
2021-11-15
(Crawled : 14:00)
- ir.anaptysbio.com
ANAB
|
$21.47
0.61%
0.61%
300K
|
Health Technology
|
-34.84%
|
O:
-0.27%
H:
0.0%
C:
0.0%
phase 1
positive
topline
phase 2
phase 3
Moderna Announces Positive Data from Phase 2 Study of mRNA VEGF-A Therapeutic in Patients Undergoing Coronary Artery Bypass Grafting Surgery
Published:
2021-11-15
(Crawled : 14:00)
- biospace.com/
MRNA
|
News
S
|
$103.45
-0.33%
-0.33%
2M
|
Health Technology
|
-54.05%
|
O:
2.19%
H:
0.0%
C:
0.0%
phase 2
positive
Rocket Pharmaceuticals Announces Positive Updates from Phase 1 Clinical Trial of RP-A501 in Danon Disease
Published:
2021-11-15
(Crawled : 13:00)
- biospace.com/
RCKT
M
|
$23.7
-2.27%
-2.32%
640K
|
Health Technology
|
-29.94%
|
O:
-1.63%
H:
0.0%
C:
-23.94%
disease
phase 1
positive
trial
phase 2
phase 3
rp-a501
danon disease
2-THE-TOP Phase 2 Trial Reports Positive Top-Line Results in Newly Diagnosed Glioblastoma
Published:
2021-11-15
(Crawled : 13:00)
- biospace.com/
NVCR
|
$12.04
-3.37%
-3.49%
1.4M
|
Health Technology
|
-88.95%
|
O:
3.0%
H:
0.39%
C:
-3.17%
phase 2
positive
results
trial
topline
glioblastoma
Protagonist Therapeutics Announces Positive Phase 2a Data Supporting the Potential Use of Rusfertide as a First-in-Class Therapy in Hereditary Hemochromatosis
Published:
2021-11-15
(Crawled : 12:00)
- prnewswire.com
PTGX
|
$25.55
-2.15%
-2.19%
520K
|
Health Technology
|
-26.62%
|
O:
4.69%
H:
0.0%
C:
0.0%
phase 2
potential
positive
therapy
phase 2b
Addex Strategic Partner Successfully Completes Phase 1 in Japan with ADX71149
Published:
2021-11-15
(Crawled : 09:00)
- biospace.com/
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-13.64%
|
O:
-1.36%
H:
0.0%
C:
0.0%
ADXN
|
$22.8
0.89%
0.88%
16K
|
Health Technology
|
-85.38%
|
O:
2.85%
H:
1.14%
C:
1.14%
phase 1
phase 2
xin
phase 3
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.